Medpace Holdings Company Profile (NASDAQ:MEDP)

About Medpace Holdings (NASDAQ:MEDP)

Medpace Holdings logoMedpace Holdings, Inc. is a clinical contract research organization. The Company provides clinical research-based drug and medical device development services. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology & Medical Research - NEC
  • Sub-Industry: N/A
  • Symbol: NASDAQ:MEDP
  • CUSIP: N/A
  • Web: www.medpace.com
Capitalization:
  • Market Cap: $1.23 billion
  • Outstanding Shares: 39,487,000
Average Prices:
  • 50 Day Moving Avg: $29.46
  • 200 Day Moving Avg: $29.29
  • 52 Week Range: $21.76 - $38.94
P/E:
  • Trailing P/E Ratio: 54.93
  • Foreward P/E Ratio: 19.14
  • P/E Growth: 2.01
Sales & Book Value:
  • Annual Revenue: $378.52 million
  • Price / Sales: 3.25
  • Book Value: $15.30 per share
  • Price / Book: 2.04
Profitability:
  • EBIDTA: $110.08 million
  • Net Margins: 5.37%
  • Return on Equity: 9.32%
  • Return on Assets: 5.88%
Debt:
  • Debt-to-Equity Ratio: 0.28%
  • Current Ratio: 0.79%
  • Quick Ratio: 0.79%
Misc:
  • Average Volume: 191,638 shs.
  • Short Ratio: 3.91
 

Frequently Asked Questions for Medpace Holdings (NASDAQ:MEDP)

What is Medpace Holdings' stock symbol?

Medpace Holdings trades on the NASDAQ under the ticker symbol "MEDP."

How were Medpace Holdings' earnings last quarter?

Medpace Holdings, Inc. (NASDAQ:MEDP) issued its quarterly earnings data on Monday, July, 31st. The company reported $0.38 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.30 by $0.08. The business earned $94.60 million during the quarter, compared to analysts' expectations of $92.71 million. Medpace Holdings had a return on equity of 9.32% and a net margin of 5.37%. The company's revenue for the quarter was up 2.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.45 EPS. View Medpace Holdings' Earnings History.

When will Medpace Holdings make its next earnings announcement?

Medpace Holdings is scheduled to release their next quarterly earnings announcement on Wednesday, November, 1st 2017. View Earnings Estimates for Medpace Holdings.

What guidance has Medpace Holdings issued on next quarter's earnings?

Medpace Holdings updated its FY17 earnings guidance on Monday, July, 31st. The company provided earnings per share (EPS) guidance of $1.36-1.46 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.35. The company issued revenue guidance of $373-385 million, compared to the consensus revenue estimate of $376.90 million.

Where is Medpace Holdings' stock going? Where will Medpace Holdings' stock price be in 2017?

6 brokers have issued 12-month price targets for Medpace Holdings' shares. Their forecasts range from $31.00 to $36.00. On average, they anticipate Medpace Holdings' share price to reach $34.00 in the next twelve months. View Analyst Ratings for Medpace Holdings.

What are analysts saying about Medpace Holdings stock?

Here are some recent quotes from research analysts about Medpace Holdings stock:

  • 1. According to Zacks Investment Research, "Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. " (8/3/2017)
  • 2. Jefferies Group LLC analysts commented, "Medpace boasts eye-popping margin, strong cash flow, and an enticing correlation to fast growing biotech customers. With its group-high valuation, MEDP's risk, in our view, is that investors have looked through management's "conservative" guidance to upsides, akin to prior CRO post-IPO performances. 1.05x BtB, lower 2017 revenue guidance, and in-line EPS will likely pressure the stock a little on Tuesday." (2/28/2017)

Who are some of Medpace Holdings' key competitors?

Who are Medpace Holdings' key executives?

Medpace Holdings' management team includes the folowing people:

  • August J. Troendle M.D., Chairman of the Board, President, Chief Executive Officer
  • Jesse J. Geiger CPA, Chief Financial Officer, Chief Operating Officer - Laboratory Operations
  • Susan E. Burwig, Executive Vice President - Operations
  • Penelope J. Bucknell, Vice President - Human Resources
  • Stephen P. Ewald J.D., General Counsel, Corporate Secretary
  • Anastasya Molodykh, Director
  • John R. Richardson, Director
  • Bruce Brown, Independent Director
  • Brian T. Carley, Independent Director
  • Robert O. Kraft, Independent Director

When did Medpace Holdings IPO?

(MEDP) raised $150 million in an IPO on Thursday, August 11th 2016. The company issued 7,000,000 shares at $20.00-$23.00 per share. Jefferies, Credit Suisse, UBS Investment Bank and Wells Fargo Securities acted as the underwriters for the IPO and Baird and William Blair were co-managers.

Who owns Medpace Holdings stock?

Medpace Holdings' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include CINVEN CAPITAL MANAGEMENT (V) GENERAL PARTNER LTD (56.40%), Vanguard Group Inc. (2.57%), Bernzott Capital Advisors (1.46%), Acadian Asset Management LLC (1.19%), Granite Investment Partners LLC (0.69%) and Redmile Group LLC (0.57%). Company insiders that own Medpace Holdings stock include August J Troendle and Susan E Burwig. View Institutional Ownership Trends for Medpace Holdings.

Who sold Medpace Holdings stock? Who is selling Medpace Holdings stock?

Medpace Holdings' stock was sold by a variety of institutional investors in the last quarter, including TIAA CREF Investment Management LLC, Citadel Advisors LLC, Spark Investment Management LLC, Teachers Advisors LLC, Russell Investments Group Ltd., Wells Fargo & Company MN, California State Teachers Retirement System and OxFORD Asset Management LLP. View Insider Buying and Selling for Medpace Holdings.

Who bought Medpace Holdings stock? Who is buying Medpace Holdings stock?

Medpace Holdings' stock was bought by a variety of institutional investors in the last quarter, including Bernzott Capital Advisors, Granite Investment Partners LLC, Redmile Group LLC, Ameriprise Financial Inc., Vanguard Group Inc., Acadian Asset Management LLC, Fisher Asset Management LLC and Prudential Financial Inc.. Company insiders that have bought Medpace Holdings stock in the last two years include August J Troendle and Susan E Burwig. View Insider Buying and Selling for Medpace Holdings.

How do I buy Medpace Holdings stock?

Shares of Medpace Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Medpace Holdings' stock price today?

One share of Medpace Holdings stock can currently be purchased for approximately $31.20.


MarketBeat Community Rating for Medpace Holdings (NASDAQ MEDP)
Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  45 (Vote Outperform)
Underperform Votes:  59 (Vote Underperform)
Total Votes:  104
MarketBeat's community ratings are surveys of what our community members think about Medpace Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Medpace Holdings (NASDAQ:MEDP) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Hold Ratings, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $34.00 (8.97% upside)

Analysts' Ratings History for Medpace Holdings (NASDAQ:MEDP)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/2/2017Jefferies Group LLCReiterated RatingHold$30.00 -> $31.00LowView Rating Details
6/6/2017Credit Suisse GroupReiterated RatingOutperform$35.00 -> $36.00LowView Rating Details
5/3/2017Wells Fargo & CompanyDowngradeOutperform -> Market PerformHighView Rating Details
3/29/2017KeyCorpInitiated CoverageOverweight -> Overweight$34.00MediumView Rating Details
9/6/2016William BlairReiterated RatingOutperformN/AView Rating Details
9/6/2016Robert W. BairdInitiated CoverageNeutral$35.00N/AView Rating Details
(Data available from 8/20/2015 forward)

Earnings

Earnings History for Medpace Holdings (NASDAQ:MEDP)
Earnings by Quarter for Medpace Holdings (NASDAQ:MEDP)
Earnings History by Quarter for Medpace Holdings (NASDAQ MEDP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/1/2017$0.35N/AView Earnings Details
7/31/2017Q2 2017$0.30$0.38$92.71 million$94.60 millionViewN/AView Earnings Details
5/1/2017Q1 2017$0.37$0.34$93.61 million$93.80 millionViewListenView Earnings Details
2/27/2017Q416$0.34$0.35$94.40 million$95.38 millionViewListenView Earnings Details
11/3/2016Q316$0.34$0.40$91.42 million$94.80 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Medpace Holdings (NASDAQ:MEDP)
2017 EPS Consensus Estimate: $1.40
2018 EPS Consensus Estimate: $1.62
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.38$0.38$0.38
Q2 20173$0.29$0.30$0.30
Q3 20173$0.35$0.36$0.36
Q4 20173$0.35$0.38$0.36
Q1 20181$0.38$0.38$0.38
Q2 20181$0.41$0.41$0.41
Q3 20181$0.42$0.42$0.42
Q4 20181$0.41$0.41$0.41
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Medpace Holdings (NASDAQ:MEDP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Medpace Holdings (NASDAQ:MEDP)
Institutional Ownership Percentage: 19.19%
Insider Trades by Quarter for Medpace Holdings (NASDAQ:MEDP)
Institutional Ownership by Quarter for Medpace Holdings (NASDAQ:MEDP)
Insider Trades by Quarter for Medpace Holdings (NASDAQ:MEDP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/18/2016August J TroendleCEOBuy10,000$27.98$279,800.00View SEC Filing  
8/17/2016Susan E BurwigInsiderBuy19,211$29.21$561,153.31View SEC Filing  
8/16/2016August J TroendleCEOBuy869,565$23.00$19,999,995.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Medpace Holdings (NASDAQ:MEDP)
Latest Headlines for Medpace Holdings (NASDAQ:MEDP)
Source:
DateHeadline
americanbankingnews.com logoZacks: Analysts Anticipate Medpace Holdings, Inc. (MEDP) Will Announce Quarterly Sales of $95.10 Million
www.americanbankingnews.com - August 20 at 7:16 AM
reuters.com logoBRIEF-Medpace Holdings announces stock repurchase agreement with Cinven
www.reuters.com - August 18 at 6:42 AM
finance.yahoo.com logoETFs with exposure to Medpace Holdings, Inc. : August 16, 2017
finance.yahoo.com - August 17 at 2:32 AM
finance.yahoo.com logoMedpace Holdings, Inc. Announces Stock Repurchase Agreement with Cinven
finance.yahoo.com - August 17 at 2:32 AM
finance.yahoo.com logoMedpace Holdings, Inc. :MEDP-US: Earnings Analysis: Q2, 2017 By the Numbers : August 4, 2017
finance.yahoo.com - August 5 at 2:45 AM
americanbankingnews.com logoFY2019 EPS Estimates for Medpace Holdings, Inc. Raised by William Blair (NASDAQ:MEDP)
www.americanbankingnews.com - August 4 at 7:40 PM
americanbankingnews.com logoFY2017 EPS Estimates for Medpace Holdings, Inc. Raised by William Blair (MEDP)
www.americanbankingnews.com - August 3 at 9:50 AM
americanbankingnews.com logoMedpace Holdings, Inc. (MEDP) Receives Hold Rating from Jefferies Group LLC
www.americanbankingnews.com - August 2 at 4:38 PM
americanbankingnews.com logoZacks: Analysts Expect Medpace Holdings, Inc. (NASDAQ:MEDP) Will Post Quarterly Sales of $95.59 Million
www.americanbankingnews.com - August 2 at 8:26 AM
americanbankingnews.com logoJefferies Group Analysts Increase Earnings Estimates for Medpace Holdings, Inc. (MEDP)
www.americanbankingnews.com - August 2 at 7:02 AM
finance.yahoo.com logoEdited Transcript of MEDP earnings conference call or presentation 1-Aug-17 1:00pm GMT
finance.yahoo.com - August 2 at 5:09 AM
americanbankingnews.com logoHead-To-Head Contrast: Zynerba Pharmaceuticals (ZYNE) & Medpace Holdings (MEDP)
www.americanbankingnews.com - August 1 at 8:30 PM
americanbankingnews.com logoMedpace Holdings, Inc. (NASDAQ:MEDP) Announces Earnings Results
www.americanbankingnews.com - July 31 at 9:10 PM
finance.yahoo.com logoMedpace Holdings, Inc. Reports Second Quarter 2017 Results
finance.yahoo.com - July 31 at 8:09 PM
finance.yahoo.com logoMedpace tops Street 2Q forecasts
finance.yahoo.com - July 31 at 8:09 PM
americanbankingnews.com logoMedpace Holdings, Inc. (NASDAQ:MEDP) Updates FY17 Earnings Guidance
www.americanbankingnews.com - July 31 at 6:06 PM
americanbankingnews.com logoMedpace Holdings, Inc. (MEDP) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - July 29 at 7:27 AM
finance.yahoo.com logoMedpace Holdings, Inc. breached its 50 day moving average in a Bearish Manner : MEDP-US : July 28, 2017
finance.yahoo.com - July 28 at 4:02 PM
finance.yahoo.com logoETFs with exposure to Medpace Holdings, Inc. : July 27, 2017
finance.yahoo.com - July 28 at 3:56 AM
americanbankingnews.com logoFinancial Analysis: Nektar Therapeutics (NKTR) versus Medpace Holdings (NASDAQ:MEDP)
www.americanbankingnews.com - July 22 at 8:22 PM
finance.yahoo.com logoETFs with exposure to Medpace Holdings, Inc. : July 17, 2017
finance.yahoo.com - July 17 at 6:20 PM
finance.yahoo.com logoMedpace Holdings, Inc. breached its 50 day moving average in a Bullish Manner : MEDP-US : July 12, 2017
finance.yahoo.com - July 13 at 6:42 AM
americanbankingnews.com logoQ4 2017 EPS Estimates for Medpace Holdings, Inc. Increased by KeyCorp (MEDP)
www.americanbankingnews.com - July 12 at 12:55 PM
americanbankingnews.com logoMedpace Holdings, Inc. (NASDAQ:MEDP) Downgraded by Zacks Investment Research to Sell
www.americanbankingnews.com - July 12 at 7:32 AM
finance.yahoo.com logoMedpace Holdings, Inc. to Report Second Quarter 2017 Financial Results on July 31, 2017
finance.yahoo.com - July 12 at 3:26 AM
americanbankingnews.com logoQ2 2017 Earnings Forecast for Medpace Holdings, Inc. (MEDP) Issued By KeyCorp
www.americanbankingnews.com - July 11 at 8:04 AM
americanbankingnews.com logoMedpace Holdings, Inc. (MEDP) Cut to "Overweight" at KeyCorp
www.americanbankingnews.com - July 10 at 7:52 AM
americanbankingnews.com logoMedpace Holdings, Inc. (MEDP) Upgraded by Zacks Investment Research to "Hold"
www.americanbankingnews.com - July 9 at 11:32 PM
americanbankingnews.com logoZacks: Analysts Expect Medpace Holdings, Inc. (NASDAQ:MEDP) Will Announce Quarterly Sales of $93.58 Million
www.americanbankingnews.com - July 8 at 7:36 AM
americanbankingnews.com logo$0.30 Earnings Per Share Expected for Medpace Holdings, Inc. (MEDP) This Quarter
www.americanbankingnews.com - July 6 at 10:14 PM
finance.yahoo.com logoETFs with exposure to Medpace Holdings, Inc. : July 5, 2017
finance.yahoo.com - July 5 at 4:22 PM
americanbankingnews.com logoMedpace Holdings, Inc. (NASDAQ:MEDP) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - July 4 at 10:02 AM
americanbankingnews.com logoMedpace Holdings, Inc. (MEDP) to Post Q1 2018 Earnings of $0.37 Per Share, Jefferies Group Forecasts
www.americanbankingnews.com - June 30 at 9:42 AM
News IconBRIEF-Medpace Holdings says Medpace Limited Partnership entered into credit agreement
www.businessinsider.com - June 24 at 4:58 AM
americanbankingnews.com logoMedpace Holdings, Inc. (MEDP) Expected to Announce Earnings of $0.30 Per Share
www.americanbankingnews.com - June 15 at 2:06 PM
americanbankingnews.com logo$93.58 Million in Sales Expected for Medpace Holdings, Inc. (MEDP) This Quarter
www.americanbankingnews.com - June 14 at 9:36 AM
finance.yahoo.com logoMedpace Holdings, Inc. breached its 50 day moving average in a Bearish Manner : MEDP-US : June 12, 2017
finance.yahoo.com - June 12 at 9:21 AM
americanbankingnews.com logoMedpace Holdings Inc (MEDP) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - June 9 at 11:24 AM
finance.yahoo.com logoETFs with exposure to Medpace Holdings, Inc. : June 8, 2017
finance.yahoo.com - June 8 at 7:27 PM
americanbankingnews.com logoMedpace Holdings Inc (MEDP) Given "Outperform" Rating at Credit Suisse Group AG
www.americanbankingnews.com - June 6 at 3:38 PM
finance.yahoo.com logoMedpace Holdings, Inc. to Present at Two Upcoming Investor Conferences
finance.yahoo.com - June 1 at 7:18 PM
finance.yahoo.com logoMedpace Holdings, Inc. breached its 50 day moving average in a Bullish Manner : MEDP-US : June 1, 2017
finance.yahoo.com - June 1 at 9:27 AM
finance.yahoo.com logoWhat Falling Estimates & Price Mean for Medpace Holdings (MEDP)
finance.yahoo.com - May 24 at 10:51 AM
americanbankingnews.com logo Analysts Expect Medpace Holdings Inc (MEDP) Will Announce Quarterly Sales of $93.58 Million
www.americanbankingnews.com - May 21 at 2:26 PM
finance.yahoo.com logoETFs with exposure to Medpace Holdings, Inc. : May 16, 2017
finance.yahoo.com - May 16 at 6:19 PM
americanbankingnews.com logoMedpace Holdings Inc (MEDP) Lowered to "Hold" at ValuEngine
www.americanbankingnews.com - May 16 at 4:00 PM
americanbankingnews.com logo Analysts Expect Medpace Holdings Inc (MEDP) Will Announce Earnings of $0.30 Per Share
www.americanbankingnews.com - May 16 at 8:24 AM
americanbankingnews.com logoMedpace Holdings Inc (MEDP) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - May 15 at 12:10 PM
americanbankingnews.com logoShort Interest in Medpace Holdings Inc (MEDP) Increases By 24.2%
www.americanbankingnews.com - May 12 at 3:40 PM
americanbankingnews.com logoZacks Investment Research Downgrades Medpace Holdings Inc (MEDP) to Strong Sell
www.americanbankingnews.com - May 7 at 9:26 AM

Social

Chart

Medpace Holdings (MEDP) Chart for Sunday, August, 20, 2017

This page was last updated on 8/20/2017 by MarketBeat.com Staff